Cochlear Limited (ASX: COH) has appointed highly experienced Michael Daniell to the Cochlear Board, effective from 1 January 2020.
Mr Daniell has worked in the medical device industry for 40 years and has extensive executive leadership experience. Mr Daniell is currently serving as Non-Executive Director of Fisher & Paykel Healthcare.
He would be a Non-Executive Director and is considered by the Board to be independent.
At AEST 01:07 PM, the stock was trading at $228.230, down by 1.032% from the previous close.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.